Welcome to Antibodypedia.com

antibodypedia.com

Description: Antibodypedia. A portal for validated antibodies...

Google PR 0

Trustworthiness Unknown
Avg. Daily Visitors 499

Child Safety Unknown
Avg. Daily Pageviews 499

Privacy Unknown

Antibodypedia

Antibodypedia.com: get to the top rated Antibodypedia pages and content popular with USA-based Antibodypedia.com users or check the following digest to find out more. Antibodypedia.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Antibodypedia team are just starting to conquer the social media and they have already achieved a promising result — 25 user activities so far (LinkedIn dominates with around 82% of all user reactions). Antibodypedia.com is hosted with Kungliga Tekniska Hogskolan in Sweden. Antibodypedia traffic is estimated at around 15K visits per month.

Visit antibodypedia.com

Domain info

Location:	Sweden
Registrant:	Not Disclosed
Hosted by:	Kungliga Tekniska Hogskolan
Registrar:	Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Subnetworks:	130.237.80.63

Social Media Activities

Facebook likes: -
Twitter mentions: 3
Google pluses: -
LinkedIn mentions: 21
Pinterest pins: -
StumbleUpon views: 1

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Antibodypedia.com popular pages to visit

Antibodypedia A portal for validated antibodies Antibodypedia scores antibodies to guide researchers to choose an appropriate antibody for a particular application. The resource contains information about more than...

- About | Antibodypedia Antibodypedia’s mission Antibodypedia’s mission is to aid users in selecting antibodies tailored to specific biological and biomedical assays and promote transparency regarding validation of reage...

- Listed Providers | Antibodypedia Which providers list antibodies in Antibodypedia? The list of providers with antibodies in Antibodypedia is constantly evolving. At the moment, however, we catalogue antibodies from the following ...